Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health watchdog for UK up and running:

This article was originally published in Clinica

Executive Summary

The UK Commission of Health Improvement (CHI) has started work as an independent standards watchdog for the National Health Service (NHS). The CHI will monitor the quality of care within the NHS and review every hospital and primary care group in England and Wales within the next four years. The first specialty area to be reviewed will be cancer services, followed by coronary heart disease and mental health. Evidence from the reviews, which are set to start from next May, will be published on the Internet. The CHI will also work closely with the National Institute of Clinical Excellence (NICE) and monitor the quality of care throughout the NHS.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080003

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel